Anastasiia Kotaieva Sells 75,000 Shares of Nukkleus (NASDAQ:NUKK) Stock

Nukkleus Inc. (NASDAQ:NUKK) insider Anastasiia Kotaieva sold 75,000 shares of the business’s stock in a transaction dated Monday, December 29th. The stock was sold at an average price of $4.09, for a total value of $306,750.00. Following the transaction, the insider directly owned 75,000 shares of the company’s stock, valued at $306,750. This represents a 50.00% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Anastasiia Kotaieva also recently made the following trade(s):

• On Friday, December 26th, Anastasiia Kotaieva sold 55,604 shares of Nukkleus stock. The shares were sold at an average price of $4.26, for a total value of $236,873.04.
• On Wednesday, December 24th, Anastasiia Kotaieva sold 55,604 shares of Nukkleus stock. The stock was sold at an average price of $4.49, for a total value of $249,661.96.
• On Tuesday, December 23rd, Anastasiia Kotaieva sold 70,000 shares of Nukkleus stock. The shares were sold at an average price of $4.57, for a total transaction of $319,900.00.
• On Monday, December 22nd, Anastasiia Kotaieva sold 30,000 shares of Nukkleus stock. The stock was sold at an average price of $4.41, for a total transaction of $132,300.00.
• On Friday, December 19th, Anastasiia Kotaieva sold 70,000 shares of Nukkleus stock. The stock was sold at an average price of $4.53, for a total transaction of $317,100.00.
• On Thursday, December 18th, Anastasiia Kotaieva sold 38,744 shares of Nukkleus stock. The shares were sold at an average price of $4.72, for a total transaction of $182,871.68.

Nukkleus Price Performance

NUKK stock opened at $4.03 on Friday. Nukkleus Inc. has a twelve month low of $3.31 and a twelve month high of $40.98. The company has a market cap of $67.10 million, a PE ratio of 0.25 and a beta of -6.66. The business’s 50-day simple moving average is $5.53 and its 200 day simple moving average is $6.75.

Hedge Funds Weigh In On Nukkleus

Several hedge funds and other institutional investors have recently modified their holdings of the stock. BNP Paribas Financial Markets acquired a new stake in Nukkleus in the 2nd quarter valued at $56,000. Ausdal Financial Partners Inc. bought a new position in shares of Nukkleus during the third quarter valued at $105,000. Finally, UBS Group AG lifted its holdings in shares of Nukkleus by 23.3% during the third quarter. UBS Group AG now owns 80,512 shares of the company’s stock valued at $564,000 after acquiring an additional 15,223 shares during the period. Institutional investors own 12.47% of the company’s stock.

Key Headlines Impacting Nukkleus

Here are the key news stories impacting Nukkleus this week:

• Positive Sentiment: Nukkleus completed the acquisition of Israeli defense-software firm Tiltan, adding ~30 years of defense AI expertise and established vendor relationships (IAI, Elbit, Rafael). This expands Nukkleus’s product set and creates a pathway to defense-market revenue. Nukkleus Completes Tiltan Acquisition
• Neutral Sentiment: Major outlets (MSN, TipRanks) circulated the acquisition news, increasing visibility; however, the announcements lack financial detail (purchase price, projected revenue, integration plan), so near‑term earnings impact is uncertain. TipRanks Announcement
• Negative Sentiment: Insider selling: director/officer Anastasiia Kotaieva sold several large blocks across Dec. 18–29 totaling roughly 286,208 shares for about $1.25M in proceeds (sales at ~$4.09–$4.72). Concentrated insider disposals can create selling pressure and be interpreted negatively by investors. SEC Filing (Insider Sales)

Analyst Upgrades and Downgrades

NUKK has been the subject of a number of recent research reports. Weiss Ratings restated a “sell (d+)” rating on shares of Nukkleus in a research note on Wednesday, December 24th. Wall Street Zen upgraded shares of Nukkleus from a “sell” rating to a “hold” rating in a research note on Sunday, November 23rd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Nukkleus has an average rating of “Sell”.

About Nukkleus

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.